ER heart test feedback aims to cut readmissions and deaths in Rapid-Breathing patients
NCT ID NCT05699564
First seen Apr 29, 2026 · Last updated Jun 23, 2026 · Updated 10 times
Summary
This study looks at whether giving doctors early results from heart biomarker tests (NT-proBNP and hs-cTnT) along with a structured interpretation note can improve outcomes for patients admitted with rapid breathing (tachypnea). About 574 adults will be randomly assigned to receive this feedback or standard care. The main goal is to see if the feedback extends the time until a patient is readmitted to the hospital or dies from any cause.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEART FAILURE are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Akershus University Hospital
Lørenskog, Lørenskog, 1478, Norway
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
early biomarker testing (NT-proBNP and hs-cTnT) with structured feedback
What this could lead to
If successful, this could show that early biomarker-guided assessments in the ER help reduce hospital readmissions and deaths in patients with rapid breathing.
What could go wrong
This is a single-center pragmatic trial, not a large Phase 3 study. The intervention is informational feedback, not a drug, so the impact may be modest and may not apply to other hospitals.
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.